Search results
Insights from the leading minds in our industry. Explore. The Lupin Foundation works in over 4,500 villages to ensure sustainable development. Our Mission. Delivering on our promise toward innovative science and healthcare for more than five decades. How We Began.
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.
Established in 1968 by our visionary founder, Dr. Desh Bandhu Gupta, Lupin has evolved from humble beginnings to become a global healthcare leader. Headquartered in Mumbai, India, we have expanded our footprint across the U.S., LATAM, APAC and EMEA regions, operating in over 100 countries and offering adiverse portfolio of over 1,000 products.
1 day ago · Lupin Share Price Today (04 Jul, 2024): Lupin Stock Price (₹ 1752.75) Live NSE/BSE updates on The Economic Times. Check out why Lupin share price is up today. Get all details on Lupin shares news and analysis, Forecasts, Dividend, balance sheet, profit & loss, Quarterly results, annual report information, and more.
Get the latest Lupin Ltd (LUPIN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Get the latest Lupin Ltd (500257) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Lupin Limited Stock Price Today, Live NSE Share Price: Get the latest Lupin Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
1 day ago · Shares of multibagger pharma stock Lupin Ltd surged more than 5 per cent during the trading session on Thursday after the company saw a double upgrade from Kotak Institutional Equities. Lupin shares rose over 6 per cent on BSE on Thursday after brokerage Kotak Securities double upgraded the pharma firm to ‘add’.
1 day ago · Shares of Lupin hit a multi-year high at Rs 1,749, soaring 7 per cent on the BSE in Thursday’s intra-day trade backed by heavy volumes on expectation of healthy earnings. ... which will ensure a limited earnings dip in FY2027E after a strong FY2026E,” the brokerage firm said in its stock update. Analysts believes there is still a possibility of further positive surprises if Lupin continues to gain share in gSpiriva as well, if there is lower-than-expected hit from Albuterol competition.
1 day ago · Lupin stock hits eight-year high at Rs 1,749 on healthy earnings outlook Firm has a bunch of products lined up which will ensure limited earnings dip in FY27: Analysts. Lupin Pharma. Deepak Korgaonkar. ... It believes that US generic opportunities with limited competition launches and market share growth in Spiriva are likely to drive Lupin's US generic revenue to over $1 billion by FY27. ...
